Publications by authors named "Kamlesh Kunti"
Article Synopsis
- - The HOPE-3 trial is investigating the effects of statin drugs and blood pressure medications on reducing cardiovascular events in individuals at intermediate risk without previous heart issues, aiming to clarify their safety and efficacy.
- - The study involves 12,705 participants aged 55 and older, with at least one cardiovascular risk factor, who are randomly assigned to receive either the medications or a placebo over an average follow-up of 5.8 years.
- - Results from HOPE-3 are anticipated to enhance understanding of preventive treatment strategies in populations with average cholesterol and blood pressure levels, potentially influencing global health practices.
